| Politician | Branch | Asset | Ticker | Category | Type | Transaction Date | Amount | Filing Date |
|---|---|---|---|---|---|---|---|---|
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 10, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 9, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 9, 2017 | $$1,001 - $15,000 | July 5, 2018 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 8, 2017 | $$1,001 - $15,000 | July 5, 2018 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 8, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 7, 2017 | $$1,001 - $15,000 | July 5, 2018 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 7, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 7, 2017 | $$1,001 - $15,000 | July 5, 2018 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 7, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 6, 2017 | $$1,001 - $15,000 | July 5, 2018 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 6, 2017 | $$1,001 - $15,000 | July 5, 2018 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 6, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| David A Perdue , Jr | senate | Pfizer Inc. | PFE | STOCK | Purchase | Feb. 6, 2017 | $$1,001 - $15,000 | March 1, 2017 |
| James B. Renacci | house | PFIZER INCORPORATED (PFE) | PFE | STOCK | PURCHASE | Jan. 26, 2017 | $$1,000 - $15,000 | Feb. 7, 2017 |
| Thomas R Carper | senate | Pfizer Inc | PFE | STOCK | Purchase | Jan. 23, 2017 | $$1,001 - $15,000 | Feb. 6, 2017 |
| Thomas R Carper | senate | Pfizer Inc | PFE | STOCK | Purchase | Jan. 23, 2017 | $$1,001 - $15,000 | Feb. 6, 2017 |
| John Hoeven | senate | Pfizer Inc. | PFE | STOCK | Sale (Full) | Jan. 20, 2017 | $$50,001 - $100,000 | Jan. 25, 2017 |
| Brad Ashford | house | Pfizer, Inc. (PFE) | PFE | STOCK | Sale | Nov. 28, 2016 | $$1,001 - $15,000 | Dec. 5, 2016 |
| John Hoeven | senate | Pfizer Inc. | PFE | STOCK | Purchase | Nov. 25, 2016 | $$50,001 - $100,000 | Dec. 7, 2016 |
| Raúl M. Grijalva | house | Pfizer, Inc. (PFE) | PFE | STOCK | s | Sept. 19, 2016 | $$1,001 - $15,000 | Sept. 28, 2016 |
| K. Michael Conaway | house | Pfizer, Inc. (PFE) | PFE | STOCK | Purchase | Sept. 12, 2016 | $$15,001 - $50,000 | Oct. 12, 2016 |
| Linda T. Sanchez | house | Pfizer, Inc. (PFE) | PFE | STOCK | S | Aug. 9, 2016 | $$1,001 - $15,000 | Sept. 14, 2016 |
| Debbie Dingell | house | Pfizer, Inc. (PFE) | PFE | STOCK | P | Aug. 8, 2016 | $$1,001 - $15,000 | Aug. 16, 2016 |
| Debbie Dingell | house | Pfizer, Inc. (PFE) | PFE | STOCK | P | Feb. 23, 2016 | $$15,001 - $50,000 | March 2, 2016 |
| Kathy Castor | house | Pfizer, Inc. (PFE) | PFE | STOCK | Purchase | Feb. 12, 2016 | $$1,001 - $15,000 | March 18, 2016 |